Yeah, I wouldnât go in now. I could, because the french listing is available on Degiro. The price is entirely FOMO. How does anyone know how much they can supply?
Similar to Kawamoto - Stock of the month - January 2020 - #14 by Han
Novacyt #NCYT +77.78%âŠ
Corona virus test kit suppliers. In the news a lot this past few weeks so Iâm sure you have all seen.
Mainly so there is one green If the corona spread gets worse! 
I think this company would be a good addition, shares are on the up at the minute, I would imagine that this will continue during these Coronavirus times. Company also founded and based in the UK.
Technically âfoundedâ in France 
. But they have been making coronavirus test kits for at least 2 months now. Over ÂŁ8.7m in sales
Shocking this was not added 
1 Like
Novacyt please!
bump this too!
Me too! The choice of shares on this app is really hard to overlook, as much as I want to love it.
1 Like
Bump, this is one of the most important companies this year, needs to be one freetrade ASAP. Canât migrate from interactive investor until this is on
2 Likes
This has aged so well, the boat has been missed on this one 
In recent weeks, emotions around Novacyt have heated up. Well-known and respected private investor Leon Boros (@Boros10) posted a tweet suggesting that Novacytâs share price was looking âoverheatedâ. He stated that he was still holding but had much reduced his position.
The reaction to this single tweet was a lot of anger and denial, which suggested lots of emotion in the stock price.
Have we missed the boat?
I feel there is still a decent amount of growth in this company. Itâs Covid related work has created a good buzz around the company which will hopefully bring investment and expansion.
More importantly I think it could well be a company that gets brought out by one of the big players who would have the financial resources to take the work to the next level.
there is certainly a lot of emotion around novacyt, personally, as someone who requested this stock be added back in january, i do not believe their current contracts and sales warrant todayâs valuation, and even if their contracts doubled again i donât reach the current valuation. Additional concern is that governments will move away from PCR to more novel rapid testing solutions - novacyt have a rapid POC solution, but so do heaps of other companies. Itâs worth remembering that while the market may think oh there are only a handful of other listed companies offering testing solutions, there are even more private companies also offering competing services. Just because you canât invest in them doesnât mean they donât eat up market share. I sold at ÂŁ7 and am staying out unless the price corrects a lot, but that seems unlikely in the short term given the numbers of uber fans.
2 Likes
Cheers James! This was a highly insightful comment.
Meanwhile the directors seems bullish. Do you have any thoughts on this development?
https://novacytinsider.com/director-purchases/
Ultimately, I think Iâll wait and monitor the situation for a few weeks before I decide.
Link from the app is broken.
This company is still making bank from all the covid testing thatâs going on.
New C-19 variants, heading into winter
New European lockdowns
NCYT up like 50% in recent weeks, still way low compared to earlier in the year before contract failure
Do we think NCYT/Testing stocks are going to make a comeback over winter?
Private Eye article about Novayct 
ÂŁ134.6m DHSC claim 